Reports of the Demise of Medical Journal Ads Have Been Greatly Exaggerated In this 2.5-minute audio snippet, Pharmaguy presents data from Kantar Media that shows that the death of professional print pharma advertising has been greatly exaggerated. He gets into which companies and drugs have spent the most on journal advertising and summarizes a study of physician attitudes regarding these ads.
Your browser does not support the audio element. Upgrade your browser to one that does
For more about these issues, read the March 28, 2017 Pharma Industry News Update issue published on LinkedIn: